Found this: Extract below, from this url: http://www.fda.gov/Drugs/NewsEvents/ucm326450.htm
Food Drugs - Impact of Approved Drug Labeling on Chronic Opioid Therapy Part 15 Meeting The U.S. Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain. These issues include: diagnosis and understanding of patient pain, understanding and adhering to the labels of pain-treating products, limiting opioid prescriptions and use, and abuse and misuse of opioid medicines.
Date(s): February 7-8, 2013 from 9:00 a.m. to 4:00 p.m.
Location: Bethesda Marriott 5151 Pooks Hill Road Bethesda, MD 20814
Federal Register Notice (PDF - 191KB)
Registration: If you wish to attend the workshop or provide oral comments during the open session of the meeting, please register by January 18, 2013.
QRX Price at posting:
90.0¢ Sentiment: Hold Disclosure: Held